Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1979 Aug;42(2):128–132. doi: 10.1136/hrt.42.2.128

A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.

J C Forfar
PMCID: PMC482125  PMID: 486273

Full text

PDF
128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coon W. W., Willis P. W., 3rd Hemorrhagic complications of anticoagulant therapy. Arch Intern Med. 1974 Mar;133(3):386–392. [PubMed] [Google Scholar]
  2. Fleming H. A., Bailey S. M. Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J. 1971 Sep;47(551):599–604. doi: 10.1136/pgmj.47.551.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GILCHRIST A. R., TULLOCH J. A. An evaluation of anticoagulant therapy in acute myocardial infarction. Scott Med J. 1956 Jan;1(1):1–14. doi: 10.1177/003693305600100101. [DOI] [PubMed] [Google Scholar]
  4. Husted S., Andreasen F. Problems encountered in long-term treatment with anticoagulants. Acta Med Scand. 1976;200(5):379–384. doi: 10.1111/j.0954-6820.1976.tb08250.x. [DOI] [PubMed] [Google Scholar]
  5. Husted S., Andreasen F. The influence of age on the response to anticoagulants. Br J Clin Pharmacol. 1977 Oct;4(5):559–565. doi: 10.1111/j.1365-2125.1977.tb00786.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lam-Po-Tang P. R., Poller L. Oral anticoagulant therapy and its control: an international survey. Thromb Diath Haemorrh. 1975 Nov 15;34(2):419–425. [PubMed] [Google Scholar]
  7. O'Reilly R. A., Aggeler P. M. Determinants of the response to oral anticoagulant drugs in man. Pharmacol Rev. 1970 Mar;22(1):35–96. [PubMed] [Google Scholar]
  8. PEYMAN M. A. The significance of haemorrhage during the treatment of patients with the coumarin anticoagulants. Acta Med Scand Suppl. 1958;339:1–62. doi: 10.1111/j.0954-6820.1958.tb17330.x. [DOI] [PubMed] [Google Scholar]
  9. POLLARD J. W., HAMILTON M. J., CHRISTENSEN N. A., ACHOR R. W. Problems associated with long-term anticoagulant therapy. Observations in 139 cases. Circulation. 1962 Feb;25:311–317. doi: 10.1161/01.cir.25.2.311. [DOI] [PubMed] [Google Scholar]
  10. Rogers P. H., Sherry S. Current status of antithrombotic therapy in cardiovascular disease. Prog Cardiovasc Dis. 1976 Nov-Dec;19(3):235–253. doi: 10.1016/0033-0620(76)90017-7. [DOI] [PubMed] [Google Scholar]
  11. Staffurth J. S., Gibberd M. C., Fui S. N. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J. 1977 Sep 10;2(6088):688–690. doi: 10.1136/bmj.2.6088.688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Taberner D. A., Thomson J. M., Poller L. Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal. Br Med J. 1976 Jul 10;2(6027):83–85. doi: 10.1136/bmj.2.6027.83. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES